Portal:Lipids/PathwayList
From WikiPathways
(Difference between revisions)
| Line 7: | Line 7: | ||
* [https://doi.org/10.1016/j.chembiol.2004.03.025 Phosphoinositide Signaling] | * [https://doi.org/10.1016/j.chembiol.2004.03.025 Phosphoinositide Signaling] | ||
| + | * [http://dx.doi.org/10.1016/j.cell.2017.07.029 PI3-K in Human diseases] | ||
| + | * [https://doi.org/10.3390/ijms19123931 Class I PI3-K Isoforms in Endometrial Cancer] | ||
| + | * [https://en.wikipedia.org/wiki/Inositol_trisphosphate_receptor Inositol trisphosphate receptor] | ||
==== Improve existing pathways ==== | ==== Improve existing pathways ==== | ||
Revision as of 11:02, 1 October 2020
Contents |
Create new pathways
- Public resources for pathway information: LIPID MAPS and SwissLipids.
- See our Help section for New Contributor QuickStart, Editor's Palette Guide and Guidelines for Contributors.
Start a new pathway!
- Phosphoinositide Signaling
- PI3-K in Human diseases
- Class I PI3-K Isoforms in Endometrial Cancer
- Inositol trisphosphate receptor
Improve existing pathways
| Sphingolipid Metabolism (integrated pathway) (mouse) |
| Elongation of (very) long chain fatty acids (mouse) |
Contact us
Send questions about WikiPathways to the wikipathways-discuss mailing list.
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact the administrator.
